Drug Shortage Report for AXID

Last updated on 2019-02-01 History
Report ID 70676
Drug Identification Number 00778338
Brand name AXID
Common or Proper name Nizatidine
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) NIZATIDINE
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 caps
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-07-01
Actual start date 2019-01-31
Estimated end date 2019-07-23
Actual end date 2019-01-31
Shortage status Resolved
Updated date 2019-02-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-02-01 English Compare
v5 2019-02-01 English Compare
v4 2019-01-25 French Compare
v3 2019-01-25 English Compare
v2 2018-12-28 French Compare
v1 2018-12-28 English Compare

Showing 1 to 6 of 6